Phase III, randomized, open-label, multicenter trial (BREAK-3) comparing the BRAF kinase inhibitor dabrafenib (GSK2118436) with dacarbazine (DTIC) in patients with BRAFV600E-mutated melanoma.
Axel Hauschild
Consultant or Advisory Role - GlaxoSmithKline
Honoraria - GlaxoSmithKline
Research Funding - GlaxoSmithKline
Jean Jacques Grob
Consultant or Advisory Role - GlaxoSmithKline
Honoraria - GlaxoSmithKline
Lev V. Demidov
Honoraria - GlaxoSmithKline; MSD
Research Funding - Bristol-Myers Squibb; GlaxoSmithKline; Pfizer; Roche
Thomas Jouary
Consultant or Advisory Role - Bristol-Myers Squibb; Roche
Honoraria - Bristol-Myers Squibb; Roche
Ralf Gutzmer
Consultant or Advisory Role - Almirall Hermal GmbH; Bristol-Myers Squibb; GlaxoSmithKline; MSD; Novartis
Honoraria - Almirall Hermal GmbH; Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Merck Serono; Roche
Research Funding - Novartis; Roche
Other Remuneration - Bristol-Myers Squibb; MSD; Roche
Michael Millward
Consultant or Advisory Role - GlaxoSmithKline
Research Funding - GlaxoSmithKline
Piotr Rutkowski
Consultant or Advisory Role - Bristol-Myers Squibb; Novartis
Honoraria - Bristol-Myers Squibb; GlaxoSmithKline; MSD; Novartis; Pfizer
Christian U. Blank
Consultant or Advisory Role - Bristol-Myers Squibb; Novartis; Roche
Research Funding - Bristol-Myers Squibb; Novartis
Beloo Mirakhur
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
Mary E. Guckert
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
R. Suzanne Swann
Employment or Leadership Position - GlaxoSmithKline
Patricia Haney
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
Anne-Marie Martin
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
Danielle Ouellet
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
Kelly Grotzinger
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
Vicki L. Goodman
Employment or Leadership Position - GlaxoSmithKline
Stock Ownership - GlaxoSmithKline
Paul B. Chapman
Consultant or Advisory Role - GlaxoSmithKline; Roche/Genentech
Research Funding - GlaxoSmithKline; Roche/Genentech